trending Market Intelligence /marketintelligence/en/news-insights/trending/08sfUOrVImvvb6IbEY7Q1w2 content esgSubNav
In This List

Charles River Laboratories plans $500M senior notes offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Charles River Laboratories plans $500M senior notes offering

Charles River Laboratories International Inc. is planning an offering of $500 million of its senior notes maturing in 2028.

The Wilmington, Mass.-based research company plans to use the net proceeds from the offering as well as cash on hand to prepay a portion of its term loan facility and to pay related fees and expenses.

Charles River Laboratories International is an early-stage contract research company that provides drug discovery, nonclinical development and safety-testing services worldwide.